News

Business Insider4y
Oncopeptides has submitted an Investigational New Drug application to FDA for the second drug candidate from the PDC platform
STOCKHOLM, Oct. 19, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has submitted an Investigational New Drug (IND) application to the U.S ...
Nasdaq4y
Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial of CYTO-205 for the Treatment of COVID-19
Cytocom has submitted an Investigational New Drug (IND) application with updated protocols ... Cytocom has entered into an agreement with ICON plc (NASDAQ: ICLR), a global contract research ...
Business Insider3y
HUYABIO Files an Investigational New Drug Application with the FDA for the Novel SHP2 Inhibitor HBI-2376
announced today the filing of an investigational new drug application (IND) with the FDA for HBI-2376 along with Genhouse who has filed an IND with the Chinese Center for Drug Excellence CDE.
Lupus Foundation of America1y
Investigational New Drug Application for ATA3219 Submitted to the FDA for Lupus Nephritis Treatment
A new drug application for the investigational therapy, ATA3219, for treatment of systemic lupus erythematosus (SLE) with kidney involvement (lupus nephritis) has been submitted to the U.S. Food and ...
Business Wire10mon
Imbrium Therapeutics Submits Investigational New Drug Application to Evaluate Sunobinop for the Potential Treatment of Alcohol Use Disorder
STAMFORD, Conn.--(BUSINESS WIRE)--Imbrium Therapeutics L.P. (“Imbrium”), a subsidiary of Purdue Pharma L.P. (“Purdue”), has submitted an Investigational New ...
Nasdaq1y
Lexaria's Submits Investigational New Drug Application
it submitted its much-anticipated Investigational New Drug ("IND") application with the U.S. Food and Drug Administration ("FDA") for its planned U.S. phase 1b hypertension clinical trial HYPER ...
Cure Today2mon
New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application
EVM14, an mRNA cancer vaccine, received FDA clearance for investigational new drug application, advancing Everest's mRNA technology to global clinical trials. Preclinical studies showed EVM14 induces ...
Healio4mon
FDA clears investigational new drug application for Zabalafin Hydrogel
A new drug application is anticipated for 2029. The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has been cleared by the FDA ...
Morningstar3mon
GenAssist Ltd Announces FDA Clearance of Investigational New Drug Application for GEN6050X, a Globally First-in-Class Base Editing Drug for Duchenne Muscular Dystrophy
GEN6050X injection is an intravenous cytosine base editing drug designed for DMD patients amenable to exon 50 skipping. GEN6050X is based on GenAssist's unique RNA editing-free Targeted AID ...
VentureBeat11mon
Circle Pharma files first Investigational New Drug application for first-in-class oral cyclin A/B RxL inhibitor for treatment of advanced solid tumors
announced the submission of its first Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for CID-078, a first-and-only-in-class cyclin A/B RxL inhibitor.
Healio9mon
FDA clears investigational new drug application for photoreceptor disease therapy
Please provide your email address to receive an email when new articles are posted on . BlueRock Therapeutics is preparing to initiate a phase 1/2a clinical study of OpCT-001. OpCT-001 will be ...